Chung KY, Kang M, Walker JW. Contractile regulation by overexpressed ETA requires intact T tubules in adult rat ventricular myocytes. Am J Physiol Heart Circ Physiol 294: H2391-H2399, 2008. First published March 7, 2008 doi:10.1152/ajpheart.00011.2008.-Endothelin (ET)-1 regulates the contractility and growth of the heart by binding G protein-coupled receptors of the ET type A receptor (ETA)/ET type B (ETB) receptor family. ETA, the predominant ET-1 receptor subtype in myocardium, is thought to localize preferentially within cardiac T tubules, but the consequences of mislocalization are not fully understood. Here we examined the effects of the overexpression of ETA in conjunction with T-tubule loss in cultured adult rat ventricular myocytes. In adult myocytes cultured for 3 to 4 days, the normally robust positive inotropic effect (PIE) of ET-1 was lost in parallel with T-tubule degeneration and a decline in ETA protein levels. In these T tubule-compromised myocytes, an overexpression of ETA using an adenoviral vector did not rescue the responsiveness to ET-1, despite the robust expression in the surface sarcolemma. The inclusion of the actin polymerization inhibitor cytochalasin D (CD) during culture prevented gross morphological changes including a loss of T tubules and a rounding of intercalated discs, but CD alone did not rescue the responsiveness to ET-1 or prevent ETA downregulation. The rescue of a normal PIE in 3-to 4-day cultured myocytes required both an increased expression of ETA and intact T tubules (preserved with CD). Therefore, the activation of ETA localized in T tubules was associated with a strong PIE, whereas the activation of ET A in surface sarcolemma was not. The results provide insight into the pathological cardiac conditions in which ET A is upregulated and T-tubule morphology is altered. cytochalasin D; inotropism; endothelin type A receptor; heart failure THE POTENT vasoconstrictor peptide endothelin (ET)-1 is produced not only by vascular endothelial cells (46) but also by endocardial endothelial cells and cardiac myocytes (14). In the heart, ET-1 produces inotropic, chronotropic, and growthpromoting actions (30, 38) . Among these physiological effects of ET-1, the regulation of contractility has received considerable attention, with a positive inotropic effect (PIE) reported in rat, mouse, rabbit, ferret, and human but not in guinea pig or dog myocardium (18, 22, (43) (44) (45) . Biological functions of ET-1 are mediated by two G protein-coupled receptor (GPCR) subtypes, ET type A receptor (ET A ) and ET type B receptor
strated increased plasma and tissue levels of ET-1 and an increased expression of ET A in diseased human myocardium and in animal models of heart failure (1, 11, 20, 28, 31, 33, 39, 49) . Furthermore, ET A selective or nonselective antagonists have shown beneficial effects in some animal studies and in clinical trials although other studies have failed to find benefits (6, 28, 34) .
Cardiac T tubules are invaginations of the surface membrane occurring in the vicinity of Z-lines, which facilitate the propagation of external signals into the inner myocyte cross section (5) . T tubules display a unique composition of membrane lipids and Ca 2ϩ , Na ϩ , and K ϩ transport proteins along with numerous signaling molecules. Key sarcoplasmic reticulum proteins such as ryanodine receptors and sarco(endo)plasmic reticulum Ca 2ϩ -ATPase pumps are also concentrated at Z-lines adjacent to T tubules (5) . Previous studies reported that ET A is mainly localized at T tubules in adult ventricular myocytes (3, 37) , but the physiological and pathophysiological significance of the T-tubular localization of ET A is not fully understood. In pathological conditions such as failing myocardium, the structure of T tubules appears to change both in humans and animal models. The majority of studies have described a reduced or disorganized T tubule structure in heart failure although an increase of T tubule density has also been reported (2, 12, 17, 24, 41) .
In the present study, we employed an adult rat myocyte model of spontaneous T-tubule degeneration in cell culture to examine the importance of T tubules in ET A function. In conjunction with the overexpression of cyan fluorescent protein (CFP)-tagged ET A , this cellular model reinforced earlier findings that a T-tubular localization of ET A is crucial for the contractile regulation in adult ventricular myocytes (37) . This model also permitted a comparison of the functional consequences of the activation of ET A in T tubules versus surface sarcolemma (when T tubules are lost). The results shed light on the altered ET-1 signaling in cardiac disease states that is accompanied by the remodeling of myocyte membranes.
MATERIALS AND METHODS
Materials. All reagents were obtained from Sigma Chemical (St. Louis, MO) unless noted otherwise. Collagenase was from Worthington (Lakewood, NJ). Complete protease inhibitor cocktail was from Roche (Mannheim, Germany). ET A monoclonal antibody was from BD Biosciences (San Jose, CA), and Alexa 488-conjugated secondary antibodies were from Molecular Probes (Eugene, OR).
Isolation of adult rat ventricular myocytes. Animal handling practices used in this study have been reviewed by and received approval from the Animal Care Committee of the University of Wisconsin. Ventricular cardiac myocytes were isolated from adult male SpragueDawley rats by enzymatic digestion with collagenase and hyaluronidases, as previously described (13) . The myocytes were maintained in 1 mM Ca 2ϩ Ringer solution containing (in mM) 125 NaCl, 5 KCl, 2 NaH2PO4, 5 sodium pyruvate, 1.2 MgSO4, 11 glucose, 0.5 CaCl2, and 25 HEPES (pH 7.4).
Primary culture and adenoviral infection of adult rat ventricular myocytes. Isolated myocytes were resuspended in Dulbecco's modified Eagle's medium (DMEM) containing 5% fetal bovine serum, 50 U/ml penicillin and 50 g/ml streptomycin and (in mM) 1 CaCl 2, 5 taurine, 5 carnitine, and 5 creatine. The cells were plated on laminincoated coverslips by incubating at 37°C, 5% CO 2-95% room air for 2 h. After 2 h incubation, culture medium was replaced with adenovirus-diluted serum-free DMEM. After 1 h incubation, serum-free DMEM was added and changed every day.
Adenovirus construction. A human ET A was fused to the NH2 terminus of CFP in a pShuttle vector driven by cytomegalovirus promoters (Stratagene). ET A-CFP-carrying adenoviruses were generated using an AdEasy adenoviral vector system (Stratagene) according to the manufacturer's instructions. The viruses were amplified and purified by the use of a ViraKit AdenoMini-4 purification kit (Virapur, San Diego, CA).
Western blot analysis. Proteins separated by SDS-PAGE were transferred to polyvinylidene difluoride membranes (Millipore, Bedford, MA). Nonspecific sites were blocked by Blotto containing 150 mM NaCl, 20 mM Tris (pH 7.4), 0.05% (vol/vol) Tween 20, and 5% powdered milk for 1 h at room temperature, and Western blot analysis was carried out with enhanced chemiluminescence detection (GE Healthcare).
Immunofluorescence. The myocytes were skinned with 100 g/ml saponins in relaxing solution containing (in mM) 100 KCl, 1 MgCl 2, 2 EGTA, 4.5 ATP, and 10 imidazole (pH 7.0) and then washed and blocked by 2% bovine serum albumin in relaxing solution. Skinned myocytes were incubated with primary antibody overnight at 4°C. Following an extensive wash with 2% bovine serum albumin in relaxing solution, the myocytes were incubated with Alexa 488-conjugated anti-mouse IgG secondary antibody (diluted 1:200) for 1 h at room temperature. After the myocytes were extensively washed, images were acquired with a Bio-Rad MRC 1024 laser-scanning confocal microscope equipped with an argon/krypton laser controlled by 24-bit LaserSharp software.
Twitch measurements. The myocytes were resuspended in 1 mM Ca 2ϩ Ringer solution. Cell twitches were initiated by electric field stimulation with a SD9 stimulator (Grass Instrument) in a modified PH1 chamber (Warner Instrument) mounted on a Nikon Diaphot inverted microscope. The stimulation protocol was 0.5 Hz, 10-ms duration, and 50 V at room temperature. Individual myocytes were monitored with a model VED 104 video edge detector (Crescent Electronics), and cell shortening was recorded using Felix software (Photon Technology).
Confocal imaging and image analysis. Confocal images were obtained with a Bio-Rad Radiance 2100 laser-scanning confocal microscope. Quantitative analysis of T tubules and ET A-CFP expres- sion was performed with National Institutes of Health ImageJ software. To analyze T tubule structures quantitatively, two complementary approaches were used. First, myocyte images were processed using fast Fourier transform (FFT), and the intensity of first harmonic of the transformed image was measured. The intensity of first harmonic was normalized by the whole cell area. Second, the percent area was measured. Before analysis, pixels positive for 4-{2-[6-(dioctylamino)-2-naphthalenyl]ethenyl}1-(3-sulfopropyl)-pyridinium (di-8-ANEPPS) or ET A-CFP were distinguished from negative pixels by the use of a threshold. The percentage of area was obtained by dividing the integrated intensity (total number of pixels above threshold) of the myocyte interior (excluding surface sarcolemma) by the total cell area. Expression patterns of ET A-CFP in subcellular structures of myocytes were also quantified using two methods. One is the intensity of first harmonic described above. The other is percent total intensity. The percent total intensity was obtained by dividing the integrated intensity in a designated area (percinucleus, cell interior, or sarcolemma) by the total integrated intensity.
Quantification of ET A-CFP overexpression. The radiance confocal microscope was calibrated as described previously (16) , by the use of a purified bacterial expressed CFP construct provided by Dr. Dapankar Battacharaya. The concentration of the standard CFP protein was estimated by a bicinchoninic acid protein assay and by Coomassie blue binding on a SDS-PAGE gel using bovine serum albumin as a protein standard. With the use of the same microscope settings for the acquisition of cell images (laser power, pin hole dimensions, black levels, objective, etc.), the mean fluorescence was measured as a function of the concentration CFP standard in the solution. The mean fluorescence expressed within ventricular myocytes was then used to estimate the effective fluorescence concentration by comparison with the CFP standard curve, resulting in values of 680 Ϯ 72 and 930 Ϯ 94 nM at 2 and 3 days of culture, respectively. The endogenous ET A concentration was estimated at 10 6 receptor sites/30 pl per myocyte (37, 40; unpublished data) or 55 nM, such that the levels of overexpression were 12-and 17-fold at 2 and 3 days of culture, respectively.
Statistical analysis. Data are expressed as means Ϯ SE and analyzed using an unpaired Student's t-test or a one-way ANOVA (where appropriate). Values of P Ͻ 0.05 were considered to be significant for both statistical tests.
RESULTS
To address the localization pattern and physiological function of ET A in myocytes with compromised T tubules, isolated adult rat ventricular myocytes (ARVMs) were cultured for up to 3 to 4 days. It is widely recognized that adult rat myocytes lose their rectangular structure and T tubule integrity upon culture (21) . Two different strategies were used to quantify changes in T tubule structure during culture: a standard measure of percent myocyte area occupied by T tubules (after thresholding) and a FFT of images to quantify periodicity. The first of these methods (percent area) was adopted in most previous studies to quantify the amount of plasma membrane located inside of myocytes (2, 12, 13) , but this method falls short of quantifying organized T tubules. To address this limitation, our laboratory (36) and others (41) have used the FFT analysis, which transforms a two-dimensional fluorescence cell image into a frequency domain image that quantifies periodicity. For ventricular myocytes, the first harmonic in the frequency domain represents the strongest periodicity (which, based upon the spacing between harmonics, represents sarcomeric or T tubule spacing), and the brightness of the first harmonic quantifies its magnitude in the original image. Both analysis methods were performed on the same confocal fluorescence images and showed that T tubule structures were significantly reduced in 3-day cultured ARVMs (Fig. 1) . A: contractile responses to 10 nM ET-1 in fresh isolated vs. 3-day cultured ARVMs. To examine positive inotropic effect (PIE), twitch amplitudes were measured before (0 min) and 10 min after ET-1 treatment and plotted as percent increase over 0 min. *P Ͻ 0.05 compared with fresh isolated ARVMs; ϩP Ͻ 0.05 compared with before ET-1 treatment; n Ն 10. B: expression pattern of ETA in fresh isolated vs. cultured ARVMs stained with a ETAspecific primary antibody. C: overall expression levels of ETA in fresh isolated vs. cultured ARVMs. Cell lysate samples were separated by SDS-PAGE, and Western blot analyses were performed using a ETA-specific antibody. *P Ͻ 0.05; n Ն 4. Scale bar ϭ 10 m. ]out) was increased from 1 to 2 mM in fresh isolated or 3-day cultured ARVMs. Alternatively, 10 nM isoproterenol (Iso) was perfused onto fresh or cultured ARVMs. To examine PIE, twitch amplitudes were measured before (0 min) and 3 min after the Ca 2ϩ increase or the treatment with Iso. *P Ͻ 0.05 compared with before treatment; n Ն 8.
The inotropic response to ET-1 was examined to investigate the functional consequences of T-tubule loss. After 10 min exposure to 10 nM ET-1, a 44 Ϯ 15% PIE was observed in the fresh isolated ARVM, but this inotropic effect was lost after 3 days in culture ( Fig. 2A) . In parallel with this loss of contractile regulation and the disruption of T-tubule morphology, there was also a dramatic decrease in endogenous ET A localized to T tubules as assessed by immunostaining (Fig. 2B) . The level of total endogenous ET A expression monitored by Western blot analysis also decreased by 68 Ϯ 3% over 3 days in culture (Fig. 2C) .
For comparison, inotropic responses to other stimuli were evaluated in myocytes cultured for 3 days. An increase in the extracellular Ca 2ϩ concentration from 1 to 2 mM produced a 80 Ϯ 32% PIE in fresh isolated myocytes and a 46 Ϯ 17% PIE in 3-day cultured myocytes, but this difference was not statistically significant (Fig. 3) . Isoproterenol (10 nM) induced a 151 Ϯ 25% PIE in fresh isolated myocytes and a 91 Ϯ 18% PIE in 3-day cultured myocytes, and this difference was also not statistically significant (Fig. 3) . These results suggest that, despite the lack of responsiveness to ET-1, the contractile and inotropic potential is otherwise largely preserved in 3-day cultured myocytes.
To address the mechanism of this loss of ET-1 responsiveness, ET A -CFP was overexpressed to compensate for the decrease in ET A . In 2-day cultured ARVMs displaying relatively intact T tubules, ET A -CFP was localized at the perinuclear (PN) region, T tubules, and sarcolemma and gave a periodic pattern with the FFT analysis (Fig. 4, A and B) . The T tubule and sarcolemmal (SL) ET A also colocalized with the membrane marker di-8-ANEPPS (Fig. 4A) . However, when T tubules were lost in 3-or 4-day cultured cells, ET A -CFP was located primarily at the perinucleus and sarcolemma, and the periodic FFT pattern was lost (Fig. 4, A and B) . At 2 days in culture, the subcellular distribution of ET A based on the total CFP fluorescence was 18 Ϯ 2% PN, 52 Ϯ 2% intracellular structures including T tubules (Int), and 31 Ϯ 2% SL (Fig. 4C) . By 3 to 4 days in culture, the subcellular distribution changed to 12 Ϯ 2% PN, 30 Ϯ 2% Int, and 60 Ϯ 4% SL (Fig. 4C) .
To gain insight into the absolute levels of expression, we estimated the amount of the CFP-tagged receptor by a comparison with a fluorescent CFP standard (see MATERIALS AND METHODS). The effective receptor fluorescence was equivalent to 680 Ϯ 72 nM CFP at 2 days in culture and 930 Ϯ 94 nM CFP at 3 to 4 days in culture. Therefore, CFP-tagged receptors accumulated in the SL compartment as the time in culture increased from an effective fluorescence of 210 nM (0.31 ϫ 680 nM) at 2 days to 560 nM (0.60 ϫ 930 nM) at 3 to 4 days. Overall, these confocal myocyte images and the subsequent analysis support the idea that ET A -CFP is initially expressed in PN Golgi and in T-tubule structures when they are intact and available. Non-Golgi ET A then localizes predominantly at other membranes such as the SL when T tubules are not present.
Twitch responses of myocytes expressing ET A -CFP were also investigated. Two-day cultured control ARVMs showed 34 Ϯ 7% PIE by ET-1 similar to fresh isolated ARVMs (Fig. 5A) . Two-day cultured ARVMs overexpressing ET A -CFP had a larger PIE of 73 Ϯ 22% (Fig. 5A ). In contrast, 3-day cultured ARVMs, whether overexpressing ET A -CFP or not, showed virtually no response to ET-1. Therefore, the overexpression of the receptor alone could not rescue the loss of function in 3-day cultured ARVMs (Fig. 5A ). This result also suggests that ET A -CFP localized in the SL was not functional, at least in the context of regulating myocyte contractility.
To examine the role of T-tubule degeneration in the loss of function in cultured ARVMs, cytochalasin D (CD) was used. CD has been employed by others (4) to investigate the role of cytoskeletal actin since it binds to the barbed end of actin filaments preventing actin polymerization. The inclusion of CD during culture has also been shown to inhibit changes in myocyte morphology (21), which we were able to reproduce in Fig. 6 . The T-tubule quantification parameters described above were used to confirm the preservation of T tubules in CDtreated ARVMs (Fig. 6) .
Interestingly, although CD largely prevented the remodeling of cellular structures, it could not prevent the decrease in myocyte ET A protein expression over 3 to 4 days in culture (Fig. 5B) . This suggests that CD may be able to protect the cells from structural remodeling but not from all the changes that occur in culture. CD treatment by itself was also not able to rescue the reduced PIE in 3-day cultured ARVMs (Fig. 5A) , suggesting that the decline in ET A expression during culture leaves an insufficient amount of receptors to mediate inotropic responses. Therefore, we evaluated the impact on the function of combined CD treatment with ET A -CFP overexpression in cultured ARVMs. ET-1 did induce a 55 Ϯ 16% PIE in ARVMs with T tubules preserved and overexpressed ET A -CFP (Fig.  5A) , suggesting that T-tubule integrity is critical for the normal physiological function of ET A .
ET A -CFP introduced by adenoviral infection was localized within T tubules at 2 days (with or without CD) and at 3 to 4 days of culture if CD was included (Fig. 7) . The inclusion of CD also influenced the subcellular distribution of ET A -CFP expression. ET A -CFP was localized to 9 Ϯ 1% PN, 53 Ϯ 1% Int, and 40 Ϯ 2% SL when CD was included, and this pattern changed only modestly over 2 to 4 days in culture (Fig. 7) . Thus preserving T tubule structure appeared to be critical for the stable accumulation of ET A within the intracellular/Ttubular compartment, and preserving T tubules also blunted a disproportionate accumulation of ET A at the SL. Overall, normal inotropic responses of adult ventricular myocytes to ET-1 required both an adequate expression of functional ET A s and an appropriate localization of those receptors in T tubules (as illustrated in Figs. 5-7 ).
DISCUSSION
The main findings of the present study were threefold. First, a culture of ARVMs for 3 to 4 days was accompanied by a loss of T tubules, reduced T-tubule ET A expression, and a loss of responsiveness to ET-1. Second, the introduction of exogenous ET A via adenoviral gene transfer restored ET-1 responsiveness, but only if T tubule integrity was maintained. Third, overexpressed ET A was localized to PN Golgi, T tubules, and A: to examine PIE, twitch amplitudes were measured before (0 min) and 10 min after 10 nM ET-1 treatment and expressed as percent increase over 0 min. *P Ͻ 0.05 compared with before ET-1 treatment; ϩP Ͻ 0.05; n Ն 5. B: expression levels of ETA in fresh isolated and cultured ARVMs with or without CD. Cell lysate samples from either fresh isolated or cultured ARVMs were separated by SDS-PAGE, and Western blot analyses were performed using ETA-specific antibody. *P Ͻ 0.05; n Ն 4. surface sarcolemma, but surface SL ET A was not able to mediate an enhancement of myocyte contractility by ET-1.
Several methods were used in this study to analyze T-tubule structure or the T-tubular localization of ET A in ARVMs. One was percent area (in pixels) occupied by di-8-ANEPPS fluorescence after thresholding, since many other studies employed this method to quantify T-tubule integrity (2, 12, 24) . This approach measures the percent area of fluorescently labeled structures in the cell interior (not including the nucleus or perinucleus) rather than the fluorescence intensity. To complement this approach, we also quantified intracellular periodic fluorescence staining by measuring the intensity of the first harmonic of FFT images (36, 41) . This approach distinguishes intact T-tubular structures from disorganized T tubules or non-T-tubular intracellular structures, since the first harmonic represents a repeating frequency in the image. With these complementary methods, we confirmed that organized T-tubule structure largely vanishes during 3 to 4 days in primary culture of ARVMs as reported in previous studies (23, 26, 48) . The consequences of such T tubule loss during culture in the context of ion channel function have been studied extensively (26) , but to our knowledge, this is the first study to examine changes of GPCR function in T tubule-compromised cultured myocytes. This report also confirms and extends the observations of Orchard and coworkers (21) who first showed that CD dramatically blunts the morphological remodeling of cultured rat ventricular myocytes.
In the present study, ET-1 failed to induce a PIE in 3-day cultured myocytes with compromised T tubules, and ET A overexpression could not recover the abolished PIE. These results suggest that the T-tubular localization of ET A is critical for its normal function. Robu et al. (37) previously proposed the importance of the T-tubular localization of ET A by using ARVMs detubulated by osmotic shock. This detubulation method is relatively harsh, and the few myocytes that survive may not be representative of the population. Little is also known about the fate of ET receptors in various compartments following the osmotic shock treatment such that receptor internalization, degradation, or uncoupling could play a role in the loss of responsiveness to ET-1. The present study reduces some of this uncertainty by the use of a different detubulation strategy and by localizing exogenously introduced ET A with a CFP tag. This complementary approach clearly showed that ET A introduced by viral gene transfer was expressed in T tubules and in surface sarcolemma, but only when localized to periodic T tubules was it capable of regulating myocyte contractility. SL ET A was virtually nonfunctional in terms of regulating contractility.
A likely explanation for this difference in T-tubular versus SL ET A is that only in T tubules can ET A form a functional complex with appropriate downstream signaling molecules (e.g. G␣q, PLC, and PKC) (35, 37) and end effectors (e.g. L-type Ca 2ϩ channels) (12) . A recent immunoprecipitation/ proteomics approach has provided evidence consistent with endogenous ET A forming a large complex with these molecules (among others) within the T tubules (7) . Moreover, based on the present study, adenoviral-expressed ET A -CFP appears capable of integrating productively into these macromolecular signaling complexes in the T tubules. Apparently, something critical for ET A signaling is absent in the surface sarcolemma (e.g., signaling lipids, proteins, scaffolds, etc.), or the pathway is inhibited or uncoupled in some way. The possibility that the density of L-type Ca 2ϩ channels in surface sarcolemma is too low to regulate contractility is not consistent with the finding that the stimulation of ␤-receptors by isoproterenol triggers a large PIE even in detubulated ventricular myocytes (Fig. 3 ) (37) . ␤-Adrenergic receptors are known to colocalize with their downstream signaling molecules throughout the entire sarcolemma including in T tubules and surface sarcolemma (5) .
It should be noted that ET A is naturally expressed and functional in many cell types that do not contain a T-tubule compartment. ET A even regulates Ca 2ϩ handling and contractility in neonatal myocytes and stem cell-derived myocytes with, at best, poorly developed T tubules (unpublished observations). Finally, ET A expressed heterologously in a variety of cell types appears to couple quite normally to phosphoinositide turnover, Ca 2ϩ mobilization, and the endocytotic machinery, even when fused to fluorescent proteins and/or epitope tags (Ref. 10 and N. Evans and J. W. Walker, unpublished observations). Establishing the precise functional status of surfaceexpressed ET A in adult ventricular myocytes remains an important question (see below) but will require further investigation.
Potential limitations of the present study may include an unintended selection of myocytes by the requirement for culture or by the added stress of adenoviral infection. In our hands, the adenoviral expression of a green fluorescent protein construct did not detectably affect the viability of myocytes in culture, whereas the adenoviral expression of ET A -CFP may have decreased the viability of the myocyte population by twofold or more. In contrast, the addition of CD into the culture media tended to increase myocyte viability. Moreover, besides structural changes, other physiological features may be altered by culturing ventricular myocytes or by adding CD to the culture media. Control experiments in which we examined PIEs induced by extracellular Ca 2ϩ or isoproterenol did not reveal significant differences between freshly isolated and 3-day cultured myocytes. However, some electrophysiological properties have been shown to be altered in cultured myocytes, and protein expression/turnover can be altered as well (26) .
Another issue is whether the overexpression of CFP-tagged receptors accurately mimicked the physiology of ET signaling in myocytes. We estimate that the level of overexpression is 12-fold higher (at 2 days in culture) and 17-fold higher (at 3 days in culture) than normal ET receptor levels in freshly isolated adult ventricular myocytes (see MATERIALS AND METHODS). Moreover, the range of the overexpression was 4-to 17-fold at 2 days and 6-to 33-fold at 3 days in culture, and there was no detectable difference in the twitch behavior of myocytes within a given group over these ranges. The impact of a COOHterminal CFP tag on ET A function has een found to be minimal in cultured in human embryonic kidney-293 cells (N. Evans and J. W. Walker, unpublished observations). Clearly, assessing the full impact of these potential limitations will require further investigation.
Numerous studies have demonstrated an increased expression of ET A (by ϳ2-fold) in myocardium in patients with cardiac disease and in animal models of heart failure (1, 11, 20, 28, 31, 33, 39, 49) . However, several studies reported that ET-1 showed a reduced or absent PIE in myocardium or isolated myocytes from diseased hearts (15, 25, 29, 31, 42, 47) . Similarly, Pieske et al. (31) demonstrated that ET A -mediated PIE is attenuated in end-stage failing human ventricular muscle strips desspite an increase in ET A expression. These studies speculated that the desensitization of ET A and a disturbance of downstream signaling were the underlying mechanisms. The present study suggests that a mislocalization of ET A could also contribute to the attenuated responsiveness of myocytes to ET-1.
Interestingly, T tubules have been observed to be disturbed and reduced in human heart failure or animal heart failure models (2, 5, 12, 24, 41) . Therefore, it is highly possible that even though ET A is overexpressed in failing myocardium, the failing heart may be less responsive to ET-1 due to a concomitant disruption or depletion of T tubules. Another intriguing possibility to be explored is that mislocalized ET A regulates (or misregulates) processes other than contractility such as local Ca 2ϩ signaling, mitochondrial function, or gene expression with unintended consequences to a heart in stress. Targeting such mislocalized and potentially renegade ET A s may repre- sent a viable pharmacological strategy in the ongoing fight against heart disease.
